Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiva T Radhakrishnan

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Gut Microbes|July 18, 2025
Deciphering the microbiome-metabolome landscape of an inflammatory bowel disease inception cohortShiva T Radhakrishnan, Benjamin H Mullish, Marton L Olbei, et al.
Frontline Gastroenterology|September 2, 2022
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumabCharles Miller, Hanson Kwok, Paul Harrow, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Gut Microbes|July 18, 2025
Deciphering the microbiome-metabolome landscape of an inflammatory bowel disease inception cohortShiva T Radhakrishnan, Benjamin H Mullish, Marton L Olbei, et al.
Frontline Gastroenterology|September 2, 2022
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumabCharles Miller, Hanson Kwok, Paul Harrow, et al.
Pageof 2